Acuitas Therapeutics

Acuitas Therapeutics Expands Collaboration with RNATechnologies & Therapeutics Through Strategic Investment

The investment will expand RNA Technologies & Therapeutics’ operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics 8 January 2026 -- British Columbia, Canada -- Acuitas Therapeutics, the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, today announced that it has acquired a majority stake in...

Acuitas Therapeutics to Showcase LNP Delivery Platform at Four Prestigious Conferences in November 2025

29 October 2025 -- British Columbia, Canada -- Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems, today announced its participation in four upcoming conferences in November 2025. The company will present its latest advancements in LNP technology, highlighting its role in the development of next-generation therapeutic solutions, including vaccines and gene therapies,...
6190 Agronomy Road, Suite 205. Vancouver, BC V6T 1Z3

604-227-3904